EPHA7通过调节下丘脑-垂体-卵巢轴在多囊卵巢综合征排卵障碍中的分子机制研究

批准号:
81971343
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
杜艳芝
依托单位:
学科分类:
女性生殖内分泌异常及相关疾病
结题年份:
2023
批准年份:
2019
项目状态:
已结题
项目参与者:
杜艳芝
国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
微信扫码咨询
中文摘要
排卵障碍是育龄期多囊卵巢综合征(PCOS)患者不孕的主要原因,研究PCOS患者排卵障碍的分子机制是生殖健康领域的重大需求。本课题组前期研究结果(已申请专利和发表文章):EPHA7基因与C/EBPβ、KLF4和ADAMTS1等排卵关键基因存在调控关系,与PCOS排卵障碍密切相关。拟扩大临床样本量确认基因调控网络;拟对卵巢颗粒细胞或下丘脑神经元细胞条件性敲除Epha7小鼠,对去卵巢、GnRH抑制、类PCOS大鼠行外源性EPHA7注射等体内实验,研究排卵和生育力;拟对人和小鼠卵巢颗粒细胞、颗粒细胞系KGN、大鼠垂体和下丘脑神经元细胞行RNA-Seq、抑制或过表达、ChIP等体外实验,探索EPHA7在下丘脑、垂体和卵巢组织的表达差异,及EPHA7与排卵相关基因的互作机制,阐明EPHA7通过调节下丘脑-垂体-卵巢轴影响排卵和妊娠的机制。通过动物模型排卵的干预,为PCOS患者促排卵治疗提供理论基础。
英文摘要
Ovulation disorder is the main cause of infertility in reproductive women with polycystic ovary syndrome (PCOS). To study the molecular mechanism of ovulation disorder in PCOS patients is an important requirement in the field of reproductive health. In our previous research, we found the EPHA7 gene is closely related to ovulation disorder in PCOS, and it has regulatory relationships with C/EBPβ, KLF4, and ADAMTS1. We will further expand to collect more clinical samples to certify the interaction network of gene regulation. We will do some researches on mice models with ovarian or neuron in the hypothalamus -specific and conditional knockout of Epha7 gene , ovariectomized rat model, abarelix-treated (GnRH inhibition) rat model and PCOS-like rat model injected with recombinant EPHA7-Fc protein through the caudal veins, to observe the ability of ovulation-promotion and fertility. Molecular biological methods such as RNA-Seq, gene inhibition or over-expression, and ChIP of the in vitro experiments on human and mouse primary granulocyte cells, KGN cell line, rat primary pituitary cells and hypothalamus neuron cells will be conducted. EPHA7 gene expression in the hypothalamus, pituitary gland, and ovary tissues will be checked. These will help us to figure out molecular mechanisms of EPHA7 by regulating the role of the hypothalamus-pituitary-ovarian axis on ovulation and fertility of PCOS. We will intervene the ovulation of rats or mice models. These will provide the experimental and theoretical basis for the treatment of ovulation disorder in PCOS patients.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
Serum Sex Hormone Binding Globulin Concentration as a Predictor of Ovarian Response During Controlled Ovarian Hyperstimulation.
血清性激素结合球蛋白浓度作为受控卵巢过度刺激期间卵巢反应的预测因子
DOI:10.3389/fmed.2021.719818
发表时间:2021
期刊:Frontiers in medicine
影响因子:3.9
作者:Zhai J;Li S;Zhu Y;Sun Y;Chen ZJ;Du Y
通讯作者:Du Y
DOI:10.1002/jat.4225
发表时间:2021-08
期刊:Journal of Applied Toxicology
影响因子:3.3
作者:Luwei Jiao;Shang Li;Junyu Zhai;Dongshuang Wang;Hongwanyu Li;Weiwei Chu;Xueying Geng;Yanzhi Du
通讯作者:Luwei Jiao;Shang Li;Junyu Zhai;Dongshuang Wang;Hongwanyu Li;Weiwei Chu;Xueying Geng;Yanzhi Du
DOI:10.3389/fmicb.2022.1001209
发表时间:2022
期刊:FRONTIERS IN MICROBIOLOGY
影响因子:5.2
作者:Han, Qixin;Chen, Zi-Jiang;Du, Yanzhi
通讯作者:Du, Yanzhi
Altered circadian clock as a novel therapeutic target for constant darkness-induced insulin resistance and hyperandrogenism of polycystic ovary syndrome
改变生物钟作为持续黑暗诱导的胰岛素抵抗和多囊卵巢综合征高雄激素血症的新治疗靶点。
DOI:10.1016/j.trsl.2020.02.003
发表时间:2020-05-01
期刊:TRANSLATIONAL RESEARCH
影响因子:7.8
作者:Li, Shang;Zhai, Junyu;Du, Yanzhi
通讯作者:Du, Yanzhi
Data mining analysis of the prognostic impact of N(6)-methyladenosine regulators in patients with endometrial adenocarcinoma.
N-6-甲基腺苷调节剂对子宫内膜腺癌患者预后影响的数据挖掘分析
DOI:10.7150/jca.50868
发表时间:2021
期刊:Journal of Cancer
影响因子:3.9
作者:Zhai J;Li S;Li Y;Du Y
通讯作者:Du Y
甘丙肽受体1(GALR1)DNA甲基化在生物钟紊乱致多囊卵巢综合征中的作用机制研究
- 批准号:82171623
- 项目类别:面上项目
- 资助金额:59万元
- 批准年份:2021
- 负责人:杜艳芝
- 依托单位:
多囊卵巢综合征(PCOS)患者肠道菌群谱及药物治疗对肠道菌群结构的影响
- 批准号:81671414
- 项目类别:面上项目
- 资助金额:57.0万元
- 批准年份:2016
- 负责人:杜艳芝
- 依托单位:
国内基金
海外基金
